HOME >> MEDICINE >> NEWS
The power of drug advertising: Patients often get what they ask for

Direct-to-consumer (DTC) prescription drug advertising a $3.2 billion industry in the United States not only sways patients to ask for certain medications, but profoundly influences the way doctors make initial treatment decisions, according to an April 27 study in the Journal of the American Medical Association.

University of Rochester Medical Center Professor Ronald M. Epstein, M.D., had a lead role in the research, which focused on antidepressants, as they consistently rank among the top advertised drugs. The study showed that doctors prescribed antidepressants far more often when patients asked for them. Furthermore, the study revealed that consumer advertising may have competing effects on health-care quality, by promoting the overuse of drugs in some cases while also averting under use and raising consumer awareness of disease.

The study was a collaborative effort between the UR Department of Family Medicine and University of California, Davis, Center for Health Services. The corresponding author is Richard L. Kravitz, M.D., MSPH, at UC/Davis.

"One thing is clear: patients can prompt physicians to provide better care. Drug ads are one way of getting patients to prompt their physicians but it is not the best way," Epstein says. "When patients brought up non-commercial information they were more likely to get the correct treatment than if they brought up the drug advertisement."

The study was conducted from May 2003 to May 2004. The research team trained actors to pose as patients for the randomized trial, in which 298 visits were made to 152 primary care and general internists offices in Rochester, Sacramento and San Francisco. The actors surreptitiously audio-recorded the visits with small devices hidden in their purses. Doctors were recruited to take part and were reimbursed $100 per visit, plus $100 for completing surveys and $75 for staff expenses. When doctors agreed to participate and to being secretly audio-recor
'"/>

Contact: Mark Michaud
mark_michaud@urmc.rochester.edu
585-273-4790
University of Rochester Medical Center
26-Apr-2005


Page: 1 2 3

Related medicine news :

1. Biologists learn structure of enzyme needed to power molecular motor
2. High-power MRI helps Mayo Clinic surgical team predict outcomes in unusual tumor cases
3. Pulsating gels could power tiny robots
4. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
5. Leptin has powerful effect on reward center in the brain
6. Anticipation plays a powerful role in human memory, brain study finds
7. Anger and hostility speed up decline in lung power
8. Combination of three new, high-powered MRI systems at PENN is a first in the US
9. New guidelines offer power to prevent stroke
10. Brain power combined to form new $125M institute
11. Beta carotene slows decline in lung power associated with ageing

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The power drug advertising Patients often get what they ask for

(Date:5/18/2013)... CA (PRWEB) May 18, 2013 The topics ... classes are scrum framework, scrum roles, scrum meetings, scrum artifacts, ... units (8 PDUs) for attending them. , These trainings are ... It is also ideal for those who will be a ... or those who want to explore Agile and Scrum, but ...
(Date:5/18/2013)... According to the the Stevens Johnson Syndrome Foundation, ... is a severe allergic reaction usually to medicine (i). ... can quickly advance causing blistering and large areas of dead ... SJS can develop at any time and seriously affect both ... Manute Bol, passed away after he received kidney medicine which ...
(Date:5/17/2013)... YORK, May 18, 2013. Chronic trauma can inflict lasting ... Previous imaging studies of people with post-traumatic stress disorder, ... over-or under-react in response to stressful tasks, such as ... of a threatening face. Now, researchers at NYU School ... happens in the brains of combat veterans with PTSD ...
(Date:5/17/2013)... Stryker hip lawsuit claims filed ... ABG II Modular-Neck Hip Stem recall continue to move forward ... According to court documents, a Case Management Conference was held ... which time the Court, among other things, set deadlines by ... submit Fact Sheets to Defendant and Liaison Counsel. The ...
(Date:5/17/2013)... Martinson-Nicholls new slip-resistant stair treads ... renovation tread used on steps that require an ... renovation projects, our treads and nosings deliver maximum ... compliment building designs. Bold Step is strong enough ... stairs such as basement or deck steps. , ...
Breaking Medicine News(10 mins):Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 3Health News:New Bold Step Renovation Stair Treads and Nosings from Martinson-Nicholls Add Slip Resistance to Stairs 2
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
(Date:5/16/2013)... -- Nektar Therapeutics, (Nasdaq: NKTR ) President and Chief ... scheduled to present at the upcoming 2013 UBS Global Healthcare ... Sheraton New York Hotel on Tuesday, May 21, 2013 at ... accessible via a Webcast through a link posted in the ... http://www.nektar.com . This Webcast will be available for replay until ...
(Date:5/16/2013)... 2013  Alere Inc. (NYSE: ALR ), a ... health at home through the merger of rapid diagnostics and ... share on its Series B Convertible Perpetual Preferred Stock (NYSE: ... holders of record of Series B stock at the close ... will cover the amount of all dividends accrued from April ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
Cached News: